Device Trial Radar · NCT04990089
VIVO European Observational Registry
Last checked: Nov 20, 2026Latest source record: Jan 31, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
125
Actual
Start
Oct 21, 2021
Primary completion
Jun 28, 2024
Study completion Sep 28, 2024
Sponsor
- Lead sponsor
- Catheter Precision. Inc.Not on our public-company list
- Sponsor type
- Industry
- First posted
- Aug 4, 2021
Design
- Study type
- Observational
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
A multi-center, observational registry conducted in Europe and the UK to prospectively review VIVO in a clinical setting in 125 patients.
Conditions
- Ventricular Arrythmia
- Ventricular Tachycardia
- Premature Ventricular Contraction
Interventions
VIVODevice
VIVO is a per-procedural planning tool designed to non-invasively identify the origin of a ventricular arrhythmia.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Measure the effectiveness of VIVO within different types of VA proceduresTime frame: 1 day
- Measure the safety by observing adverse events related to the device and procedureTime frame: 1 day
Locations
8 sites in 5 countries. Site status is shown where the registry gives one.
Mater Private Hospital
Dublin, Ireland
Mazzoni Hospital
Ascoli Piceno, Italy
University Medical Center Groningen
Groningen, Netherlands
5 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.